# Community Health Network

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/community-health-network/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 60 |
| Citations | 8,771 |
| City | Indianapolis |
| Country | US |
| Description | Community Health Network is a research organisation in Indianapolis, US. OpenAlex records 505 works and 8,771 citations for it. 263 researchers list it as their most recent affiliation. |
| Homepage | http://www.ecommunity.com/ |
| OpenAlex ID | https://openalex.org/I4210138333 |
| Region | Indiana |
| Researchers | 263 |
| ROR ID | https://ror.org/040cn9093 |
| Type | healthcare |
| Works | 505 |

## University papers

- [Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer](https://scholariq.org/papers/effect-of-first-line-chemotherapy-combined-with-cetuximab-or-bevacizumab-on/)
- [Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas](https://scholariq.org/papers/phase-i-safety-pharmacokinetics-and-clinical-activity-study-of-lapatinib/)
- [Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma](https://scholariq.org/papers/safety-and-antitumor-activity-of-the-anti-pd-1-antibody-pembrolizumab-in/)

## University top topics

Showing 8 of 25.

- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.